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Objectives: Recent studies have demonstrated cardiac improvement in patients
supported with a ventricular assist device, suggesting that reverse remodeling and
myocardial recovery are possible. We developed an animal model of cardiac
unloading by adapting a heterotopic transplantation technique and used it to exam-
ine the pattern of functional recovery in the left ventricle of the failing heart.
Methods: Heart failure was induced in adult New Zealand rabbits by coronary artery
ligation with subsequent myocardial infarction. Animals undergoing sham operation
served as a control group. After 4 weeks or 3 months, failing hearts were trans-
planted into the necks of recipient rabbits. A left ventricular latex balloon connected
to subcutaneous tubing allowed repeated physiologic analysis on days 1 and after
transplantation and then every 5 days until day 30.
Results: Contractility (left ventricular dP/dtmax) and relaxation (left ventricular
dP/dtmin) were significantly lower in transplanted postinfarction hearts as compared
to control hearts immediately after transplantation. Both left ventricular dP/dtmax
and left ventricular dP/dtmin responses to increased preload and to -adrenergic
stimulation progressively improved to a significantly higher level after 30 days of
left ventricular unloading for the hearts that were transplanted 4 weeks after
myocardial infarction. However, this functional improvement was not detected in
failing hearts transplanted 3 months after infarction.
Conclusions: This model of cardiac unloading appears at least partially to mimic
conditions of ventricular assist devices. If performed early in the development of
heart failure, it permits improvement of contractile dysfunction and restoration of
cardiac responsiveness to mechanical and -adrenergic stimulation. Therefore this
model may constitute a novel alternative in the study of reverse remodeling in
unloaded failing hearts.
Hemodynamic support with a ventricular assist device (VAD) isusually reserved for selected patients waiting for an organ donor,making VAD use mostly a bridge to transplantation. Interestingly,a few studies have recently reported significant left ventricular(LV) functional improvement in some patients supported withmechanical pumps.1-3 Therefore VADs may be used as a bridge to
recovery, easing the need for cardiac transplantation. To date, a handful of human
studies have analyzed LV samples obtained from hearts supported with a VAD at
the time of cardiac transplantation. These analyses have shown partial reversal of the
histologic and biochemical alterations observed in failing hearts.4-8 Clearly, under-
standing this apparent reverse remodeling process that takes place during ventricular
unloading could help to develop new strategies or molecular approaches that could
favor functional recovery in assisted hearts.
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The method of heterotopic transplantation involves hav-
ing the heart perfused by circulating blood that is shunted
from the LV cavity. Thus heterotopically transplanted
hearts are, in essence, unloaded (Figure 1). The purpose of
this study was to evaluate heterotopic heart transplantation
in the rabbit as a model of LV unloading for failing hearts.
In this study we transplanted failing hearts 4 weeks or 3
months after myocardial infarction (MI) and evaluated
physiologic and biochemical indices of reverse remodeling.
Our data confirmed the role of mechanical unloading for
potential recovery of LV contractility and relaxation, espe-
cially with regard to restoration of functional recovery to
-adrenergic receptor agonist stimulation. Moreover, we
demonstrated the deleterious effect on the potential for
functional recovery of any delay in the assistance of the
failing ventricle.
Methods
Coronary Artery Ligation
Adult male New Zealand White rabbits (3 kg) were used. All
procedures were humanely performed in accordance with the
Guide for the Care and Use of Laboratory Animals prepared by the
Institute of Laboratory Animal Resources, National Research
Council, and published by the National Academy Press, revised
1996, and were approved by the Animal Care and Use Committee
of Duke University. Animals were anesthetized with ketamine (60
mg/kg) and acepromazine maleate (INN: acepromazine, 1.0 mg/
kg), intubated, and mechanically ventilated. MI was induced by
ligation of a marginal branch of the left circumflex coronary artery
as previously described elsewhere.9,10 Sham operations on control
animals consisted of thoracotomy and opening of the pericardium
only.
Heterotopic Transplantation
Both donor and recipient animals (3-kg male New Zealand White
rabbits) were anesthetized as described. Cardioplegic arrested do-
nor hearts were transplanted into the cervical location of the
recipient rabbit with anastomoses of the donor ascending aorta to
the recipient carotid artery and the donor pulmonary artery to the
recipient jugular vein.11 Dexamethasone (4 mg/kg) was adminis-
tered intravenously before reperfusion as well as on every subse-
quent postoperative day. Special care was taken to remove the air
from the cardiac cavities before unclamping. Hearts resumed vig-
orous contraction within 3 minutes of reperfusion. Total cold
ischemic time approximated 45 minutes. In summary, donor ca-
rotid arterial blood retroperfused the ascending aorta of the trans-
planted heart and normally irrigated its coronaries. Blood was then
drained into the right atrium before being directed to the right
ventricle and ejected into the pulmonary artery and the recipient
jugular vein (Figure 1). Thus the left heart cavities were entirely
shunted, and consequently the LV was unloaded.
Left Ventricular Balloon Positioning and Repeated
Left Ventricular Functional Assessment
A latex balloon was positioned in the LV cavity through the left
atrium and mitral valve. The balloon was connected to a piece of
tubing conducted under the skin toward the animal’s back. This
system permitted a remote access to the LV cavity so that record-
ing of LV pressures could be performed repeatedly with the animal
under light anesthesia (ketamine at 40 mg/kg and acepromazine at
0.5 mg/kg) initially on days 1 and 5 and subsequently every 5 days
through day 30. Except during measurement procedures, the bal-
loon was kept deflated to allow complete LV unloading. For
measurements a high-fidelity pressure transducer (Millar Instru-
ments, Inc, Houston, Tex) was introduced into the tubing until its
tip was into the LV balloon. Basal LV end-diastolic volume
(LVEDV) was standardized by adjusting the balloon volume to
give the LV end-diastolic pressure (LVEDP) of 0 mm Hg. Three
preload conditions were studied (baseline, 0.1 mL, and 0.3 mL). In
addition, we tested the response to stimulation with the -adren-
ergic agonist isoproterenol (INN isoprenaline).
Statistical Analysis
Data are expressed as mean SEM. Unpaired Student t tests were
used for comparisons between groups. One-way analysis of vari-
ance for repeated measures with the Tukey-Kramer posttest cor-
rection was used to analyze ventricular function after heterotopic
transplantation.
Results
We considered LV function measured 24 hours after hete-
rotopic transplantation as baseline function so that the po-
tential effects of cardioplegia after the surgical procedure
could be considered nonsignificant. Our extensive experi-
ence with this rabbit MI model has demonstrated that LV
infarct size must be at least 30% of the free wall to induce
significant heart failure in rabbits at 3 to 4 weeks after MI.9
Therefore hearts with a smaller infarction were not used for
heterotopic transplantation. Accordingly, hearts after MI
had a significantly diminished LV function relative to a
Figure 1. Schematic representation of blood circulation within
heterotopically transplanted heart. Oxygenated blood originating
from one recipient artery (carotid artery [CA] in our case) ret-
roperfuses donor aorta (Ao) and irrigates coronary arteries of
transplanted heart while aortic valve prevents regurgitation into
LV. Coronary sinus drains myocardial blood into right cavities,
whence it is ejected toward donor pulmonary artery (PA) and
recipient vein (jugular vein [JV] in our case). RA, Right atrium; RV,
right ventricle.
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control group of heterotopically transplanted hearts with
sham ligation. Several parameters were altered in the failing
hearts, including contractility (LV dP/dtmax) and relaxation
(LV dP/dtmin) under basal conditions as well as in response
to increased preload or to the -adrenergic receptor agonist
isoproterenol (data not shown). Importantly, the degree of
heart failure 4 weeks after LV infarction was stable, with no
significant functional changes observed in hearts analyzed 3
months after infarction.
Whereas a single initial dose of steroids allowed the
heart to beat for only 7 days (data not shown), a daily dose
of dexamethasone permitted the heterotopically trans-
planted heart to beat normally and regularly for more than
30 days. Moreover, histologic examination of tissues from
animals that received a single dose of steroids at the time of
heterotopic transplantation demonstrated a massive immune
reaction 5 days after heterotopic transplantation (data not
shown), whereas only a moderate infiltration was present
after 30 days in hearts treated with a daily dose of steroids
(Figure 2). The reason for this reaction is that, unlike the
isogenic strains of rats in which this heterotopic transplan-
tation technique is widely used, farm-raised rabbits are
allogeneic, and thus this procedure cannot be considered an
isograft condition.
LV function was assessed every 5 days until day 30 after
heterotopic transplantation. In assessing recovery of the
ventricular functional response to preload, both LV contrac-
tility (LV dP/dtmax) and LV relaxation (LV dP/dtmin) re-
sponses to the higher LVEDV (0.3 mL) tested were signif-
icantly improved relative to an LVEDV of 0.1 mL (Figure
3). Similarly, we observed a recovery of the response to
stimulation with the -adrenergic receptor agonist isopro-
Figure 2. Comparison of representative histologic slices obtained from native heart of recipient rabbit (A and C) and
from heterotopically transplanted heart 30 days after transplantation (B and D). Slight infiltration with polymor-
phonuclear cells (B, hematoxylin and eosin) and zones of fibrosis (D, trichrome-Masson stain) can be seen in
heterotopically transplanted heart as compared with native heart (A, hematoxylin and eosin; C, trichrome-Masson
stain), accounting for moderate chronic rejection.
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terenol (Figure 3). Also, the pressure/volume relationship
significantly increased during this period (Figure 4). Thus
unloading of the failing heart by heterotopic transplantation
resulted in sustained reversal of ventricular dysfunction.
Myocardial functional recovery of failing hearts is diffi-
cult to predict, because it certainly depends on reversibility
of cellular alterations that take place progressively during
the development of heart failure. We therefore hypothesized
that prolonged delay before ventricular unloading might
impair the potential for functional recovery. To verify this
assumption, we compared functional evolution during a
20-day period of ventricular unloading in hearts that were in
failure for 3 weeks versus 3 months. Interestingly, we found
that after a postinfarction delay of 3 months before hetero-
topic transplantation and subsequent ventricular unloading,
no significant improvement in LV function could be ob-
served in any of the conditions tested (Figure 5). In addition,
the LV pressure generated during systole did not improve
after 20 days of ventricular unloading in hearts in failure for
3 months, whereas a significant increase was observed in
hearts supported by heterotopic transplantation 3 weeks
after MI (Figure 6).
Discussion
Other than studies of human samples obtained from VAD-
supported failing hearts at the time of transplantation, only
a few animal studies have examined the effects of myocar-
dial unloading,12,13 and to date no animal model of cardiac
unloading of failing hearts has been well characterized. The
heterotopically transplanted heart reproduces, at least in
Figure 3. LV contractility (LV dP/dtmax, A and B) and relaxation (LV dP/dtmin, C and D) in failing hearts unloaded for
30 days (n  5). Values were obtained every 5 days, with (B and D) or without (A and C) stimulation with
isoproterenol (ISO) at 0.1 g/(kg  min) under two preload conditions: LVEDV of basal plus 0.1 mL (open squares
and filled squares) and LVEDV of basal plus 0.3 mL (open triangles and filled triangles). Results are expressed as
percentage of basal value obtained at day 1 with preload of 0 mL and without isoproterenol stimulation. Asterisk
indicates P < .05 by 1-way analysis of variance for repeated measures; dagger indicates P < .05 for preload of
basal plus 0.1 mL; double dagger indicates P < .001 for preload of basal plus 0.3 mL.
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part, the situation of a mechanically assisted LV. Although
it is normally perfused, the LV is entirely unloaded, pro-
viding the aortic valve is competent. We used an adapted
technique to assess LV function repeatedly in lightly anes-
thetized rabbits.14 With this model, we showed that LV
function of failing rabbit hearts can partially recover when
unloaded for a sufficient period. Interestingly, we observed
no significant improvements in contractility and relaxation
in ventricles preloaded with small LVEDV as we adjusted
LVEDV to 0 mm Hg as our basal condition. However,
during the initial 30 days of ventricular unloading, we
observed a progressive improvement in the functional re-
sponse to increased preload as well as to -adrenergic
receptor agonist stimulation. Therefore both mechanical and
hormonal responses were restored in these hearts. These
findings are important, because they confirm this model to
be a reproducible way of studying ventricular recovery after
development of heart failure. Importantly, these findings
also mimic observations recently completed in human stud-
ies in which the use of a mechanical VAD allowed improve-
ment of ventricular function and, in some cases, weaning
from the mechanical pump.15
Functional improvement was first reported in case re-
ports16-20before a few series of patients supported these
observations.1-3,21,22 In addition, recovery of contractile
function was confirmed in vitro with isolated human cardi-
omyocytes.6,23 Because donor organs remain a major limit-
ing factor for cardiac transplantation, the concept of reverse
remodeling and myocardial recovery is extremely attractive.
However, factors affecting recovery are poorly understood,
even though molecular changes have clearly been demon-
strated in unloaded human ventricles. For example, tran-
scription of apoptosis-inhibiting genes is upwardly regulat-
ed,7,24 endothelin receptor A level is normalized,8
interleukin 6 and 8 levels are normalized,25 sarcoplasmic
endoreticular calcium adenosine triphosphatase subtype 2a
protein level is increased, and gene expressions of other
proteins involved in the myocardial calcium metabolism are
increased.23 Desensitization of the -adrenergic receptor
system is one of the characteristic alterations observed in
cardiomyocytes from failing hearts.9,26 Consequently, re-
sponse to -adrenergic receptor stimulation is limited in
patients as well as in animal models of heart failure, includ-
ing rabbits with coronary ligation.9,10 Thus restoration of the
-adrenergic receptor level might be one of the mechanisms
involved in functional recovery in unloaded failing hearts.
This speculation is supported by our observation of a pro-
gressive improvement in contractile function in response to
-adrenergic receptor stimulation and is also supported by
other studies performed with human samples.6
Myocardial recovery after VAD support is generally
unpredictable. However, it is generally agreed that pro-
longed heart failure leads to sustained myocardial remodel-
ing and eventually to irreversible damage.27 Subsequently,
the chance for myocardial recovery is impaired. For various
reasons, management of HF usually involves VAD implan-
tation as a last chance solution, mostly as a bridge to
transplantation. By this time of end-stage heart failure, most
hearts have extended myocardial cellular and extracellular
alterations together with multiple organ dysfunction. This
probably at least in part explains the low incidence of
myocardial recovery observed in large series of VAD place-
ments.2 Our data are in accordance with these clinical
observations, with no recovery of failing rabbit hearts that
Figure 4. Progression of LV pressure/volume relationship in unloaded failing hearts (4 weeks after coronary
ligation, n  5). LVEDP responses to increased preload are shown for day 1 (open squares), day 5 (filled triangles),
day 15 (open triangles), and day 30 (filled squares). Asterisk indicates P < .05 versus day 1.
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were held 3 months after MI before being unloaded by
heterotopic transplantation. In these hearts, as opposed to
failing hearts assisted earlier in the development and pro-
gression of heart failure, basal LV function as well as
response to mechanical and -adrenergic receptor stimula-
tion did not improve during an unloading period of 20 days.
This model thus confirms the clinical suspicion that the
delay before ventricular unloading represents a critical fac-
tor for successful functional recovery.15
Samples obtained from patients’ LVs at the time of VAD
implantation or heart transplantation have predominantly
been used to analyze histologic, biochemical, and molecular
changes that occur in unloaded hearts. Even though analyz-
ing reverse remodeling in humans is an ultimate goal, this
approach presents several limitations. First of all, the lim-
ited use of VADs and an insufficient pool of organ donors
make the number of samples available for laboratory anal-
ysis extremely low. Moreover, as stated previously, VADs
are usually used late in the course of heart failure and thus
represent an advanced, mostly irreversible, stage of heart
failure. Cardiomyopathy may also be due to various etio-
pathologic mechanisms, and different types of medical
treatment may support the patients. Such heterogeneity
makes the results difficult to interpret, especially when
looking for prognostic factors for recovery. With these
complexities in mind, our rabbit model of heterotopic trans-
plantation constitutes an attractive and relatively rapid and
feasible way to better characterize the reverse remodeling
Figure 5. Comparison of 20-day period of unloading on ventricular function in failing hearts 3 weeks after coronary
ligation (n  5, A and C) versus 3 months after coronary ligation (n  3, B and D). LV contractility (LV dP/dtmax,
A and B) and relaxation (LV dP/dtmin, C and D) are shown for different hemodynamic conditions. Asterisk indicates
P < .05 for basal versus mechanical stimulation; dagger indicates P < .05 for basal versus isoproterenol (ISO)
stimulation; double dagger indicates P < .001 for basal versus mechanical and isoproterenol stimulation.
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processes that occur during ventricular unloading. Impor-
tantly, it may allow correlation of biochemical or molecular
findings with the presence or absence of functional recov-
ery.
In conclusion, the heterotopic transplantation technique
in small animals reproduces the situation of an unloaded
heart and potentially offers significant insight into the mech-
anisms of myocardial recovery. Reverse alteration of -ad-
renergic receptor signaling may be critically involved in this
process. Although further investigations are required, our
findings suggest that VAD support, possibly in combination
with other therapeutic modalities such as gene therapy,11,28
might be beneficial in terms of functional recovery in a
greater proportion of cases.
We thank K. Campbell for excellent technical assistance.
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